All the ten filtered compounds were subjected to carcinogenicity and only those compounds selected which were non-carcinogenic, non-hepatotoxic, and found to be with potential blood-brain barrier permeability
32 Of particular note, nearly one-third of our patient population (31.7%) had not had a trial of any medications proposed for managing ME/CFS symptoms
GLP-1 side effects are often gastrointestinal, such as nausea or indigestion
Long-term research on Sermorelin and Ipamorelin has generally demonstrated excellent tolerability, with the primary adverse events being mild injection site irritation
However, the medication's effect on gastric emptying can produce symptoms that closely mimic lactose intolerance, leading to confusion
A Google Trends study published in the National Library of Medicine found a significant and growing public interest in GLP-1 agonists between 2023 and 2024